Sphingolipids in Inflammation: From Bench to Bedside

Kazuyuki Kitatani 1 and Kazuhisa Iwabuchi 2 and Ashley Snider 3,4 and Laura Riboni 5 1, Tohoku Medical Megabank Organization/Department of Obstetrics and Gynecology, Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8573, Japan 2, Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Chiba, Japan 3, Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA 4, Northport Veterans Affairs Medical Center, Northport, NY, USA 5, Department of Medical Biotechnology and Translational Medicine, LITA-Segrate, University of Milan, Milan, Italy Received 21 January 2016; Accepted 27 January 2016; 24 February 2016 This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The articles in this special issue not only provide novel findings in sphingolipid pathobiology, but also discuss the evidence collected from a large number of research articles, giving insight into drug discovery for inflammation-associated diseases.